MyAverix Finance MyAverix Finance

LSE · Healthcare

MaxCyte Inc (MXCT)

Medical Devices

MaxCyte Inc (MXCT) is listed on LSE in the Healthcare sector. Industry: Medical Devices. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for MXCT

P/E ratio
18.00

MaxCyte Inc (MXCT) — FAQ

What is MXCT's P/E ratio?

The price-to-earnings (P/E) ratio for MaxCyte Inc (MXCT) is 18.00 (data as of 2026-03-23).

Does MaxCyte Inc pay a dividend?

Dividend yield is not available in the current snapshot for MaxCyte Inc (MXCT). Check the MyAverix Finance app for the latest dividend data.

What sector is MaxCyte Inc in?

MaxCyte Inc (MXCT) is classified in the Healthcare sector (Medical Devices industry).

What exchange is MXCT listed on?

MXCT is listed on LSE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play